Singapore Diagnostic Labs Market By Provider Type (Stand-Alone Diagnostic Labs, Hospital-Based Diagnostic Labs, Diagnostic Chains), By Test Type (Pathology v/s Radiology), By End User (Referrals, Walk-ins, Corporate Clients), By Region, Competition Forecast and Opportunities 2018-2028
Singapore diagnostic labs market is projected to witness impressive growth during the forecast period. The industry has observed a huge transformation since the historic years. The growing consciousness among people about their well-being and longevity has urged them to get themselves regularly tested to keep a track record of their vital stats and to sustain their health quotient.
Singapore diagnostic labs market is expected to grow significantly in the projected period, owing to the increasing attraction of premium regional medical tourists in Singapore because of the high-quality healthcare treatment services offered by the country. Genetic tests that involve the identification of DNA, RNA, genes, and chromosomes are also gaining considerable popularity in the country, which can boost the market. In addition, rising collaborations and acquisitions in the diagnostic lab segment can unfold several growth opportunities.
Adoption of Point-of-Care Testing (PoCT) and Home Sample Collection Services
The COVID-19 pandemic altered the diagnostic market's reach and capabilities while highlighting the importance of diagnosis and treatment. Consumer adoption of point-of-care testing (PoCT) and home sample collection increased. Also, equating with online consultations, done with the help of telehealth as well as telemedicine services, diagnostic labs have started to offer diagnoses at the doorsteps of consumers. This has been achieved with the help of technological innovation and has reconditioned the entire healthcare segment. In addition, there are several people who, to get their regular health screening done, do not pay a visit to their physicians simply because of issues like standing in queues and long waiting hours. To assist this scenario, Singapore has house call doctors that perform a full-body check-up at home, thus, expanding the Singapore diagnostic labs market.
Moreover, some companies like SATA CommHealth in Singapore are providing accessible and reasonable mobile medical amenities at the earliest and professionally. This is being carried out with the aid of their mobile medical services squad, which is inclusive of a fleet of X-ray buses and a Mammo-on-Wheels bus. With considerable assistance from a group of doctors, radiographers, nurses, drivers, and clinic assistants, a broad range of facilities like health screening are brought together that can result in the timely detection of chronic disorders like respiratory illnesses, high blood pressure, and diabetes. This advancement in the country's diagnostic services is likely to propel the Singapore diagnostic labs market.
Automation in Diagnostic Laboratories
By carefully integrating robotics and laboratory automation software, laboratory automation systems are helping labs simplify procedures. Laboratories effectively manage rising test volumes, make better use of workers, and cut costs by automating processes related to testing.
To enable successful execution, price management, workforce management, and system integration are essential. With a limited labor force, automation strives to handle rising workload demands, eliminate errors, and improve laboratory performance. It takes a coordinated strategy that incorporates best practices in lean work processes, IT support, and qualified staff to improve laboratory functions rather than simply buying technologically advanced equipment. The adoption of technology is undoubtedly easing the challenges of these unpredictable times in this period of industry competition over a declining workforce.
Market Segmentation
The Singapore diagnostic labs market is segmented based on provider type, test type, end-user, region, and company. Based on provider type, the market is categorized into stand-alone diagnostic labs, hospital-based diagnostic labs, and diagnostic chains. Based on test type, the market is split into pathology & radiology. Based on end users, the market is fragmented into referrals, walk-ins, and corporate clients.
Market players
Innoquest Diagnostics Pte. Ltd., Raffles Diagnostics Pte. Ltd., Parkway Laboratory Services Ltd., Quest Laboratories Pte. Ltd., National Healthcare Group Diagnostics, Pathology & Clinical Laboratory Pte. Ltd., Reste Laboratories Pte. Ltd., Biomedics Laboratory Pte. Ltd., Acumen Diagnostics Pte. Ltd., Lifescan Imaging Pte. Ltd. are the key players operating in the Singapore Diagnostic Labs market.
Report Scope:
In this report, Singapore diagnostic labs market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Singapore diagnostic labs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Singapore diagnostic labs market is expected to grow significantly in the projected period, owing to the increasing attraction of premium regional medical tourists in Singapore because of the high-quality healthcare treatment services offered by the country. Genetic tests that involve the identification of DNA, RNA, genes, and chromosomes are also gaining considerable popularity in the country, which can boost the market. In addition, rising collaborations and acquisitions in the diagnostic lab segment can unfold several growth opportunities.
Adoption of Point-of-Care Testing (PoCT) and Home Sample Collection Services
The COVID-19 pandemic altered the diagnostic market's reach and capabilities while highlighting the importance of diagnosis and treatment. Consumer adoption of point-of-care testing (PoCT) and home sample collection increased. Also, equating with online consultations, done with the help of telehealth as well as telemedicine services, diagnostic labs have started to offer diagnoses at the doorsteps of consumers. This has been achieved with the help of technological innovation and has reconditioned the entire healthcare segment. In addition, there are several people who, to get their regular health screening done, do not pay a visit to their physicians simply because of issues like standing in queues and long waiting hours. To assist this scenario, Singapore has house call doctors that perform a full-body check-up at home, thus, expanding the Singapore diagnostic labs market.
Moreover, some companies like SATA CommHealth in Singapore are providing accessible and reasonable mobile medical amenities at the earliest and professionally. This is being carried out with the aid of their mobile medical services squad, which is inclusive of a fleet of X-ray buses and a Mammo-on-Wheels bus. With considerable assistance from a group of doctors, radiographers, nurses, drivers, and clinic assistants, a broad range of facilities like health screening are brought together that can result in the timely detection of chronic disorders like respiratory illnesses, high blood pressure, and diabetes. This advancement in the country's diagnostic services is likely to propel the Singapore diagnostic labs market.
Automation in Diagnostic Laboratories
By carefully integrating robotics and laboratory automation software, laboratory automation systems are helping labs simplify procedures. Laboratories effectively manage rising test volumes, make better use of workers, and cut costs by automating processes related to testing.
To enable successful execution, price management, workforce management, and system integration are essential. With a limited labor force, automation strives to handle rising workload demands, eliminate errors, and improve laboratory performance. It takes a coordinated strategy that incorporates best practices in lean work processes, IT support, and qualified staff to improve laboratory functions rather than simply buying technologically advanced equipment. The adoption of technology is undoubtedly easing the challenges of these unpredictable times in this period of industry competition over a declining workforce.
Market Segmentation
The Singapore diagnostic labs market is segmented based on provider type, test type, end-user, region, and company. Based on provider type, the market is categorized into stand-alone diagnostic labs, hospital-based diagnostic labs, and diagnostic chains. Based on test type, the market is split into pathology & radiology. Based on end users, the market is fragmented into referrals, walk-ins, and corporate clients.
Market players
Innoquest Diagnostics Pte. Ltd., Raffles Diagnostics Pte. Ltd., Parkway Laboratory Services Ltd., Quest Laboratories Pte. Ltd., National Healthcare Group Diagnostics, Pathology & Clinical Laboratory Pte. Ltd., Reste Laboratories Pte. Ltd., Biomedics Laboratory Pte. Ltd., Acumen Diagnostics Pte. Ltd., Lifescan Imaging Pte. Ltd. are the key players operating in the Singapore Diagnostic Labs market.
Report Scope:
In this report, Singapore diagnostic labs market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Singapore Diagnostic Labs Market, By Provider Type:
- Stand-Alone Diagnostic Labs
- Hospital-Based Diagnostic Labs
- Diagnostic Chains
- Singapore Diagnostic Labs Market, By Test Type:
- Pathology
- Radiology
- Singapore Diagnostic Labs Market, By End User:
- Referrals
- Walk-ins
- Corporate Clients
- Singapore Diagnostic Labs Market, By Region:
- Central & East Region
- West Region
- North Region
- North-East Region
Company Profiles: Detailed analysis of the major companies present in Singapore diagnostic labs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. SERVICE OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
4.1. Brand Awareness
4.2. Factors Affecting the Choice of Diagnostic Laboratory
4.3. Preference Among Population, By Provider Type
5. SINGAPORE DIAGNOSTIC LABS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Provider Type (Stand-Alone Diagnostic Labs, Hospital-Based Diagnostic Labs, Diagnostic Chains)
5.2.2. By Test Type (Pathology v/s Radiology)
5.2.3. By End User (Referrals, Walk-ins, Corporate Clients)
5.2.4. By Region (Central & East Region, West Region, North Region, North-East Region)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Provider Type
5.3.2. By Test Type
5.3.3. By End User
5.3.4. By Region
6. SINGAPORE STAND ALONE DIAGNOSTIC LABS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By End User
7. SINGAPORE HOSPITAL BASED DIAGNOSTIC LABS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By End User
8. SINGAPORE DIAGNOSTIC CHAINS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.1.1. Automation in Diagnostic Laboratories
9.1.2. Growing Awareness Amongst People about their Well-being
9.1.3. Adoption of Point-of-Care Testing (PoCT) and Home Sample Collection Services
9.2. Challenges
9.2.1. Inaccuracy in Diagnostic Tests Results
9.2.2. Dearth of Skilled Professionals
9.2.3. Repetitive Tests due to Inappropriate Sample Volume
10. MARKET TRENDS & DEVELOPMENTS
10.1. Growing Medical Tourism
10.2. Evolution of Genetic Testing
10.3. Mergers & Acquisitions
11. POLICY AND REGULATORY LANDSCAPE
12. LIST OF TOP 10 DIAGNOSTIC LABORATORIES
12.1. Top 10 Labs in Central & East Region
12.2. Top 10 Labs in West Region
12.3. Top 10 Labs in North Region
12.4. Top 10 Labs in North-East Region
13. PRICING ANALYSIS OF DIFFERENT TESTS OFFERED BY TOP FIVE PLAYERS
13.1. Blood Glucose
13.2. Cholesterol
13.3. COVID-19
13.4. Follicular Stimulating Hormone (FSH)
13.5. Thyroid Stimulating Hormone (TSH)
13.6. Magnesium
13.7. Calcium
14. DIGITALIZATION ACROSS LABORATORIES IN SINGAPORE
15. SINGAPORE ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (In Case of Listed Companies)
16.5. Key Personnel
16.5.1. Innoquest Diagnostics PTE. LTD.
16.5.2. Raffles Diagnostica PTE. LTD.
16.5.3. Parkway Laboratory Services Ltd.
16.5.4. Quest Laboratories PTE. LTD.
16.5.5. National Healthcare Group Diagnostics
16.5.6. Pathology & Clinical Laboratory PTE. LTD.
16.5.7. Reste Laboratories PTE. LTD.
16.5.8. Biomedics Laboratory PTE. LTD.
16.5.9. Acumen Diagnostics PTE. LTD.
16.5.10. Lifescan Imaging PTE. LTD.
17. STRATEGIC RECOMMENDATIONS
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
4.1. Brand Awareness
4.2. Factors Affecting the Choice of Diagnostic Laboratory
4.3. Preference Among Population, By Provider Type
5. SINGAPORE DIAGNOSTIC LABS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Provider Type (Stand-Alone Diagnostic Labs, Hospital-Based Diagnostic Labs, Diagnostic Chains)
5.2.2. By Test Type (Pathology v/s Radiology)
5.2.3. By End User (Referrals, Walk-ins, Corporate Clients)
5.2.4. By Region (Central & East Region, West Region, North Region, North-East Region)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Provider Type
5.3.2. By Test Type
5.3.3. By End User
5.3.4. By Region
6. SINGAPORE STAND ALONE DIAGNOSTIC LABS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By End User
7. SINGAPORE HOSPITAL BASED DIAGNOSTIC LABS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By End User
8. SINGAPORE DIAGNOSTIC CHAINS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.1.1. Automation in Diagnostic Laboratories
9.1.2. Growing Awareness Amongst People about their Well-being
9.1.3. Adoption of Point-of-Care Testing (PoCT) and Home Sample Collection Services
9.2. Challenges
9.2.1. Inaccuracy in Diagnostic Tests Results
9.2.2. Dearth of Skilled Professionals
9.2.3. Repetitive Tests due to Inappropriate Sample Volume
10. MARKET TRENDS & DEVELOPMENTS
10.1. Growing Medical Tourism
10.2. Evolution of Genetic Testing
10.3. Mergers & Acquisitions
11. POLICY AND REGULATORY LANDSCAPE
12. LIST OF TOP 10 DIAGNOSTIC LABORATORIES
12.1. Top 10 Labs in Central & East Region
12.2. Top 10 Labs in West Region
12.3. Top 10 Labs in North Region
12.4. Top 10 Labs in North-East Region
13. PRICING ANALYSIS OF DIFFERENT TESTS OFFERED BY TOP FIVE PLAYERS
13.1. Blood Glucose
13.2. Cholesterol
13.3. COVID-19
13.4. Follicular Stimulating Hormone (FSH)
13.5. Thyroid Stimulating Hormone (TSH)
13.6. Magnesium
13.7. Calcium
14. DIGITALIZATION ACROSS LABORATORIES IN SINGAPORE
15. SINGAPORE ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (In Case of Listed Companies)
16.5. Key Personnel
16.5.1. Innoquest Diagnostics PTE. LTD.
16.5.2. Raffles Diagnostica PTE. LTD.
16.5.3. Parkway Laboratory Services Ltd.
16.5.4. Quest Laboratories PTE. LTD.
16.5.5. National Healthcare Group Diagnostics
16.5.6. Pathology & Clinical Laboratory PTE. LTD.
16.5.7. Reste Laboratories PTE. LTD.
16.5.8. Biomedics Laboratory PTE. LTD.
16.5.9. Acumen Diagnostics PTE. LTD.
16.5.10. Lifescan Imaging PTE. LTD.
17. STRATEGIC RECOMMENDATIONS
